{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:45Z","timestamp":1792686285957,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2015,10,29]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              There is significant practice variation in oral anticoagulation (\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              ) use following catheter ablation for atrial fibrillation. It is not clear whether the risk of cardioembolism increases after discontinuation of\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              following catheter ablation.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We identified 6886 patients within a large national administrative claims database who underwent catheter ablation for atrial fibrillation between January 1, 2005, and September 30, 2014. We assessed the effect of time off of\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              by\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c score (after adjusting for other comorbidities) on risk of cardioembolism, using Cox proportional hazards models. There was an increase in the use of non\u2013vitamin K\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              after ablation from 0% in 2005 to 69.8% in 2014.\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              discontinuation was high, with only 60.5% and 31.3% of patients remaining on\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              at 3 and 12\u00a0months, respectively. The rate of discontinuation was higher in low\u2010risk patients (82% versus 62.5% at 12\u00a0months for\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c 0\u20131 versus \u22652, respectively;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001). Stroke occurred in 1.4% of patients with\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c \u22652 and 0.3% of those with\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c 0 or 1 over the study follow\u2010up. The risk of cardioembolism in the first 3\u00a0months after ablation was increased among those with any time off\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              (hazard ratio 8.06 [95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              1.53\u201342.3],\n              <jats:italic>P<\/jats:italic>\n              &lt;0.05). The risk of cardioembolism beyond 3\u00a0months was increased with\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              discontinuation among high\u2010risk patients (hazard ratio 2.48 [95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              1.11\u20135.52],\n              <jats:italic>P<\/jats:italic>\n              &lt;0.05) but not low\u2010risk patients.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The overall risk of stroke in postablation patients is low; however,\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              discontinuation after ablation is common and is associated with increased risk of cardioembolism for all patients within the first 3\u00a0months and for high\u2010risk patients in the long\u00a0term. Continuing\n              <jats:styled-content style=\"fixed-case\">OAC<\/jats:styled-content>\n              for at least 3\u00a0months in all patients and indefinitely in high\u2010risk patients appears to be the safest strategy.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.115.002597","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T03:18:53Z","timestamp":1446779933000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":80,"title":["Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation"],"prefix":"10.1161","volume":"4","author":[{"given":"Peter A.","family":"Noseworthy","sequence":"first","affiliation":[{"name":"Heart Rhythm Section, Cardiovascular Diseases, Mayo Clinic, Rochester, MN"},{"name":"Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Yao","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek J.","family":"Deshmukh","sequence":"additional","affiliation":[{"name":"Heart Rhythm Section, Cardiovascular Diseases, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Van Houten","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Sangaralingham","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos C.","family":"Siontis","sequence":"additional","affiliation":[{"name":"Heart Rhythm Section, Cardiovascular Diseases, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Sr","given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Asirvatham","sequence":"additional","affiliation":[{"name":"Heart Rhythm Section, Cardiovascular Diseases, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Heart Rhythm Section, Cardiovascular Diseases, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Packer","sequence":"additional","affiliation":[{"name":"Heart Rhythm Section, Cardiovascular Diseases, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[{"name":"Heart Rhythm Section, Cardiovascular Diseases, Mayo Clinic, Rochester, MN"},{"name":"Division of Cardiology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay D.","family":"Shah","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Mayo Clinic, Rochester, MN"},{"name":"Optum Labs, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.022"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/M13-1467"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.1561"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.111.966408"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.0038"},{"key":"e_1_3_3_8_2","unstructured":"Optum . Core US data assets. 2014. Available at: http:\/\/www.optum.com\/content\/dam\/optum\/resources\/productSheets\/5302_Data_Assets_Chart_Sheet_ISPOR.pdf. Accessed November 03 2015."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.02.020"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.109330"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.111.962688"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000032240.28636.BD"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.9143"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.03.031"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.01.044"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.11.046"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.10.052"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.039"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu421"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2009.01512.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2009.01481.x"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12387"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.111.963231"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-013-9835-1"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.12.008"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2007.04.005"},{"key":"e_1_3_3_29_2","first-page":"2071","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January CT","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;130:2071\u20132104.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.039"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-014-9944-5"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00489-1"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.076"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.115.002597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:26:43Z","timestamp":1715596003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.115.002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,10,29]]}},"alternative-id":["10.1161\/JAHA.115.002597"],"URL":"https:\/\/doi.org\/10.1161\/jaha.115.002597","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]},"assertion":[{"value":"2015-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-10-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e002597"}}